DGX logo

DGX Quest Diagnostics Incorporated

New York Stock Exchange · Medical - Diagnostics & Research · Healthcare

$234.40
-1.64 (-0.69%)

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While…

Market Cap: $25.87Bwww.questdiagnostics.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
808793100
Aug 12Aug 14

Quote

Day Range
$233.66 – $236.64
52-Week Range
$171.18 – $240.13
Volume
$398.2K
Market Cap
$25.87B
50-Day Avg
$215.36
200-Day Avg
$196.60
Prev Close
$236.04
Open
$236.64

Valuation & Ratios

P/E Ratio
19.56
EPS
$8.94
P/B Ratio
2.69
P/S Ratio
1.75
Debt/Equity
0.96
Current Ratio
1.04
Dividend Yield
+1.8%
Gross Margin
+31.9%

Returns & Efficiency

Return on Equity
+13.8%
Return on Assets
+6.1%
FCF Yield
+7.1%
EV/EBITDA
11.74

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$11.04B$992.00M$8.87
2024$9.87B$871.00M$7.80
2023$9.25B$854.00M$7.59
2022$9.88B$946.00M$8.12
2021$10.79B$2.00B$15.90

Social Signal Score

41
5d
41
2 mentions
30d
41
2 mentions
60d
41
2 mentions
90d
41
2 mentions
news: 2

Earnings

Tue, Oct 20(in 2 months)

Consensus estimate $2.85 per share

7of 7 quarters beat consensus

Typical surprise +2.8% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Jul 23$3.12 vs $2.82beat
  • Tue, Apr 21$2.50 vs $2.37beat
  • Tue, Feb 10$2.42 vs $2.36beat
  • Tue, Oct 21$2.60 vs $2.50beat
  • Tue, Jul 22$2.62 vs $2.57beat
  • Tue, Apr 22$2.21 vs $2.15beat

Estimates and results for DGX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from DGX's reported EPS growth of -13.6% a year over 4 years.

EPS in 5 years
$4.30
Implied price
$86.06
Return from $234.40
-18.2% a year

To earn 15.0% a year on these assumptions you'd need to buy at $42.79 -81.7% below today's price.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E1417202326
-23.6%-32.6%-29.9%-27.6%-25.6%-23.7%
-18.6%-28.2%-25.4%-22.9%-20.7%-18.7%
-13.6%-23.8%-20.8%-18.2%-15.8%-13.8%
-8.6%-19.4%-16.2%-13.4%-11.0%-8.8%
-3.6%-15.0%-11.6%-8.7%-6.1%-3.8%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (2)

  • Newszacks.com·1d ago·Neutral

    Quest Diagnostics (DGX) Is Up 2.29% in One Week: What You Should Know Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Let's find out.

    View source ↗
  • Newsprnewswire.com·2d ago·Negative

    Quest Diagnostics Declares Quarterly Cash Dividend SECAUCUS, N.J., Aug. 12, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on October 21, 2026 to shareholders of record of Quest Diagnostics common stock on October 6, 2026.

    View source ↗